Inhibition of Renal Sodium–Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose

The objective of this study was to examine the effect of renal sodium–glucose cotransporter inhibition with empagliflozin on the fasting plasma glucose (FPG) concentration and β-cell function in subjects with impaired fasting glucose (IFG). Eight subjects with normal fasting glucose (NFG) and eight...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Diabetes
Главные авторы: Abdul-Ghani, Muhammad, Al Jobori, Hussein, Daniele, Giuseppe, Adams, John, Cersosimo, Eugenio, Triplitt, Curtis, DeFronzo, Ralph A.
Формат: Artigo
Язык:Inglês
Опубликовано: American Diabetes Association 2017
Предметы:
Complications
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7301341/
https://ncbi.nlm.nih.gov/pubmed/28611037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db17-0055
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы